Cibus, Inc. (CBUS)
1.66
-0.03
(-1.78%)
USD |
NASDAQ |
Dec 10, 16:00
1.66
0.00 (0.00%)
Pre-Market: 09:25
Cibus Total Liabilities (Quarterly): 278.20M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Phio Pharmaceuticals Corp. | 1.666M |
| CEL-SCI Corp. | 13.31M |
| AIM ImmunoTech, Inc. | 11.57M |
| IGC Pharma, Inc. | 1.651M |
| NovaBay Pharmaceuticals, Inc. | 1.853M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 330.23M |
| Shareholders Equity (Quarterly) | 50.40M |
| Debt to Equity Ratio | 5.148 |
| Current Ratio | 1.276 |
| Net Debt Paydown Yield | -11.64% |